Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Lung cancer Clinical Trials

Protocol Number Title
2010CG036
CALGB 30901 Randomized Phase II Study of Maintenance Pemetrexed VS Observation for Patients with Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
2010NTLS088
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth: A CBPR RCT
2011NTLS081
Evaluating the Effectiveness of Reduced Nicotine Cigarettes, part of "Evaluating New Nicotine Standards for Cigarettes"
2011NTLS154
Benzo[a]pyrene Metabolism: Phenotyping and Genotyping Study 4: Deuterated Phenanthrene and NNK Cigarettes
2012CG003
CITN11-02: A phase 1 study of recombinant human IL15 (rhIL15) in adults with advanced solid tumors
2012NTLS018
Smoking, Sex Hormones, and Pregnancy
2013IS044
An open-label, parallel-group, multicenter phase I study to investigate the pharmacokinetics of NKTR-102 for injection (Etirinotecan pegol) in patients with advanced or metastatic solid tumors and mild or moderate hepatic impairment (Nektar 12-102-13)
2013IS050
A Phase 2, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second-or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma (MedImmune D4880C00003)
2013IS059
(11-PIR-09 ) An Open-Label, Multicenter, extension study of NKTR-102 in subjects previously enrolled in NKTR-102 studies
2013IS105
(Genentech GO28915) A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (ANTI-PD-L1 ANTIBODY) compared with Docetaxel in patients with non-small cell lung cancer after platinum failure (OAK)
2013IS117
C14018 : A Randomized, Double-blind, Placebo-controlled, Phase 2 Clinical Trial of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)
2013NTLS053
Understanding Cigarette Smoking Patterns Within Minnesota Somali Community Around Ramadan

12 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on